SallyJDenardoMD

Nuclear Medicine • Sacramento, CA

Physician

Join to view full profile

Are you Dr. Denardo?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 19 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
4501 X St
Suite 3016
Sacramento, CA 95817
Phone+1 916-734-3787

Fax+1 916-451-2857
Is this information wrong?

Summary

Dr. Sally Denardo, MD is a board certified nuclear medicine physician in Sacramento, California.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1969 - 1971
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1965 - 1969
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1965

Certifications & Licensure

American Board of Nuclear Medicine Nuclear Medicine

Clinical Trials

Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer Start of enrollment: 1996 Apr 01
Unknown status
Phase 1

Publications & Presentations

PubMed

18 citations
Concepts, consequences, and implications of theranosis
Gerald L. DeNardo, Sally J. DeNardo> ;Seminars in Nuclear Medicine. 2012 May 1
12 citations
In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma.
Allison L. Zwingenberger, Michael S. Kent, Ruiwu Liu, David L. Kukis, Erik R. Wisner, Sally J. DeNardo, Sandra L. Taylor, Xiucui Chen, Kit S. Lam> ;Plos One. 2012 Apr 24
9 citations
A general chemical synthesis platform for crosslinking multivalent single chain variable fragments
Joan G. Schellinger, Avinash Kudupudi, Arutselvan Natarajan, Wenjun Du, Sally J. DeNardo, Jacquelyn Gervay-Hague> ;Organic & Biomolecular Chemistry. 2012 Feb 3
15 citations
Halogenated Benzimidazole Carboxamides Target Integrin α4β1 on T-Cell and B-Cell Lymphomas
Richard D. Carpenter, Arutselvan Natarajan, Edmond Y. Lau, Mirela Andrei, Danielle M. Solano, Felice C. Lightstone, Sally J. DeNardo, Kit S. Lam, Mark J. Kurth> ;Cancer Research. 2010 Jul 1
6 citations
Dose Intensified Molecular Targeted Radiotherapy for Cancer—Lymphoma as a Paradigm
Gerald L. DeNardo, Sally J. DeNardo> ;Seminars in Nuclear Medicine. 2010 Mar 1
Health care in the United States in 2009: both sides of the "counter".
Gerald L. DeNardo, Sally J. DeNardo> ;Cancer Biotherapy & Radiopharmaceuticals. 2009 Oct 1
32 citations
111In-LLP2A-DOTA Polyethylene Glycol–Targeting α4β1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies
Sally J. DeNardo, Ruiwu Liu, Huguette Albrecht, Arutselvan Natarajan, Julie L. Sutcliffe, Carolyn J. Anderson, Li Peng, Riccardo Ferdani, Simon R. Cherry, Kit S. Lam> ;Journal of Nuclear Medicine. 2009 Apr 1
24 citations
Update: Turning the heat on cancer.
Gerald L. DeNardo, Sally J. DeNardo> ;Cancer Biotherapy & Radiopharmaceuticals. 2008 Dec 1
7 citations
Nanomolecular HLA-DR10 Antibody Mimics : A Potent System for Molecular Targeted Therapy and Imaging
Gerald L. DeNardo, Arutselvan Natarajan, Saphon Hok, Gary R. Mirick, Sally J. DeNardo, Michele Corzett, Vladimir V. Sysko, Joerg Lehmann, Laurel A. Beckett, Rod Balhorn> ;Cancer Biotherapy & Radiopharmaceuticals. 2008 Dec 1
12 citations
Update: Systemic Radiotherapy Can Cure Lymphoma: A Paradigm for Other Malignancies?
Gerald L. DeNardo, Sally J. DeNardo, Rod Balhorn> ;Cancer Biotherapy & Radiopharmaceuticals. 2008 Aug 1
63 citations
NanoFerrite Particle Based Radioimmunonanoparticles: Binding affinity and in vivo pharmacokinetics
Arutselvan Natarajan, Cordula Gruettner, Robert Ivkov, Gerald L. DeNardo, Gary R. Mirick, Aina Yuan, Allan Foreman, Sally J. DeNardo> ;Bioconjugate Chemistry. 2008 Jun 3
8 citations
Short communication: nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells.
Joerg Lehmann, Arutselvan Natarajan, Gerald L. DeNardo, Robert Ivkov, Allan Foreman, Christopher Catapano, Gary R. Mirick, Tony Quang, Cordula Gruettner, Sally J. DeNardo> ;Cancer Biotherapy & Radiopharmaceuticals. 2008 Apr 1
33 citations
Development of multivalent radioimmunonanoparticles for cancer imaging and therapy.
Arutselvan Natarajan, Cheng-Yi Xiong, Cordula Gruettner, Gerald L. DeNardo, Sally J. DeNardo> ;Cancer Biotherapy & Radiopharmaceuticals. 2008 Feb 25
19 citations
Selective High-Affinity Ligand Antibody Mimics for Cancer Diagnosis and Therapy: Initial Application to Lymphoma/Leukemia
Rod Balhorn, Saphon Hok, Patricia A. Burke, Felice C. Lightstone, Monique Cosman, Adam Zemla, Gary R. Mirick, Julie Perkins, Arutselvan Natarajan, Michele Corzett, Sal...> ;Clinical Cancer Research. 2007 Sep 15
Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissues.
Christine L. Hartmann Siantar, Gerald L. DeNardo, Kit S. Lam, Aina Yuan, Thomas P. Daly, Sally J. DeNardo> ;Cancer Biotherapy & Radiopharmaceuticals. 2007 Sep 5
62 citations
Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma
Gerald L. DeNardo, Arutselvan Natarajan, Saphon Hok, Julie Perkins, Monique Cosman, Sally J. DeNardo, Felice C. Lightstone, Gary R. Mirick, Laird Miers, Rodney L. Balhorn> ;Journal of Nuclear Medicine. 2007 Aug 1
1 citations
Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.
Orazio Schillaci, Gerald L. DeNardo, Sally J. DeNardo, Desiree S. Goldstein, Linda A. Kroger, Robert T. O'Donnell, Kathleen R. Lamborn> ;Cancer Biotherapy & Radiopharmaceuticals. 2007 Aug 1
2 citations
Recombinant Expression of the β-Subunit of HLA-DR10 for the Selection of Novel Lymphoma Targeting Molecules
Huguette Albrecht, Monique Cosman, Maria Ngu-Schwemlein, Michele Corzett, Kena W. Curran, Cheryl Dolan, Xiangming Fang, Sally J. DeNardo, Gerald L. DeNardo, Rod Balhorn> ;Cancer Biotherapy & Radiopharmaceuticals. 2007 Aug 1
10 citations
Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemia.
Saphon Hok, Arutselvan Natarajan, Rod Balhorn, Sally J. DeNardo, Gerald L. DeNardo, Julie Perkins> ;Bioconjugate Chemistry. 2007 Mar 21
92 citations
Thermal Dosimetry Predictive of Efficacy of 111In-ChL6 Nanoparticle AMF–Induced Thermoablative Therapy for Human Breast Cancer in Mice
Sally J. DeNardo, Gerald L. DeNardo, Arutselvan Natarajan, Laird Miers, Allan Foreman, Cordula Gruettner, Grete N. Adamson, Robert Ivkov> ;Journal of Nuclear Medicine. 2007 Mar 1
19 citations
Development of tissue plasminogen activator specific "on demand cleavable" (odc) linkers for radioimmunotherapy by screening one-bead-one-compound combinatorial peptid...
Pappanaicken R. Kumaresan, Arutselvan Natarajan, Aimin Song, Xiaobing Wang, Ruiwu Liu, Gerald L. DeNardo, Sally J. DeNardo, Kit S. Lam> ;Bioconjugate Chemistry. 2007 Jan 1
8 citations
Direct antilymphoma activity of novel, first-generation "antibody mimics" that bind HLA-DR10-positive non-Hodgkin's lymphoma cells.
Jeremy West, Julie Perkins, Saphon Hok, Rodney L. Balhorn, Felice C. Lightstone, Monique Cosman, Sally J. DeNardo, Gerald L. DeNardo> ;Cancer Biotherapy & Radiopharmaceuticals. 2006 Dec 1
2 citations
Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer
Joerg Lehmann, Gerald L. DeNardo, Aina Yuan, Sui Shen, Robert T. O'Donnell, Carol M. Richman, Sally J. DeNardo> ;International Journal of Radiation Oncology, Biology, Physics. 2006 Nov 15
19 citations
Cure of incurable lymphoma
Gerald L. DeNardo, Vladimir V. Sysko, Sally J. DeNardo> ;International Journal of Radiation Oncology, Biology, Physics. 2006 Oct 1
29 citations
Targeted radionuclide therapy for solid tumors: An overview
Sally J. DeNardo, Gerald L. DeNardo> ;International Journal of Radiation Oncology, Biology, Physics. 2006 Oct 1
Join now to see all

Grant Support

Lymphoma-Specific Ligands;Pharmacokinetics, Radioimaging And TherapeuticsNational Cancer Institute2007–2009
Lymphoma-Specific Ligands;Pharmacokinetics, Radioimaging And TherpeuticsNational Cancer Institute2005–2006
Novel Approaches To Pretargeted RadioimmunotherapyNational Cancer Institute2004–2006
Core--Radiopharmaceutical DevelopmentNational Cancer Institute1999–2006
Development Of Immunoconjugate Therapy For Breast CancerNational Cancer Institute1994–1999
Clinical Trials Of Biological Response ModifiersNational Cancer Institute1993–1994
Core--ImmunopathologyNational Cancer Institute1991–1993
Core--Cellular And Molecular ImmunobiologyNational Cancer Institute1991–1993
Core--Antibody PharmacyNational Cancer Institute1991–1993